Menu

Pharmaceutical Litigation

855-797-9899

Pharmaceutical Litigation

Complications
after taking
Dangerous Drugs?

Find out if you qualify
for legal recourse through
a FREE, private and no obligation
case review by our Pharma Suits
patient advocates.

Free Case Review




blog home Pharmasuits Archives | Page 2 of 9 | Farah & Farah

Pharmasuits Archives | Page 2 of 9 | Farah & Farah

Have You Been Affected by the Pharmaceutical Industry’s Unethical Behavior?

By on September 9, 2016

The U.S. Food and Drug Administration is responsible for ensuring that prescription drugs are safe for ingestion. In recent times, however, many critics of this exceptionally important government agency have emerged from around the country. Over the last few decades, an incalculable number of individuals have been harmed by drugs that were deemed safe by the FDA. Some of these drugs even led patients to develop life-threatening or deadly conditions. If you are concerned about the safety of your prescription drugs, you will find the following information to be extremely relevant. Read the rest »

Posted in: Pharmasuits

General Drug News and Your Rights as a Consumer

By on September 7, 2016

In the United States, we trust pharmaceutical companies and government agencies to ensure that our medicine is safe and effective. Unfortunately, this does not always happen, and profits and greed sometimes lead drug companies to engage in unsafe or dishonest practices. In recent times, however, numerous FDA (U.S. Food and Drug Administration)-approved drugs have been found to be unsafe, even after undergoing rigorous testing. If you have been harmed by one of these unsafe drugs, the professionals at Farah & Farah are ready to fight for your rights. Read the rest »

Posted in: Pharmasuits

Commonly Prescribed Medications Linked to Dementia

By on September 5, 2016

Proton Pump Inhibitors (PPIs) are a class of extremely popular drugs used to treat Gastroesophageal Reflux Disease (GERD or acid reflux), indigestion, heartburn, and peptic ulcers. While highly effective in treating these conditions, PPIs have also been reported to have some severe side effects, including chronic kidney disease, increased heart attack risk, birth defects, and more. Now a recent study has suggested a link between PPI use and an increased risk of dementia. Read the rest »

Posted in: Pharmasuits

Talcum Powder And Ovarian Cancer

By on September 1, 2016

Talcum powder is a widely used sanitary and cosmetic product that is distributed under the name of “baby powder” by the maker Johnson & Johnson. Over the last few decades, several studies have shown a link between talcum powder and various types of cancer, in particular, ovarian cancer. In recent times, thousands of lawsuits have been filed against manufacturers of this product, and the majority of the suits involve the development of cancer. If you believe that talcum powder is the cause of your or your loved one’s cancer, the following information may be helpful. Read the rest »

Posted in: Pharmasuits

What are the Benefits of Filing a Benicar Lawsuit?

By on August 29, 2016

If you were prescribed Benicar for hypertension or high blood pressure and suffered side effects, you likely missed a substantial amount of work and have accumulated sizeable medical bills. If you’ve suffered permanent injuries, you will have more medical costs in the future and possibly need to end your career. So how are you going to pay these bills and secure a future for you and your family? Read the rest »

Posted in: Pharmasuits

Onglyza May Be Linked to Heart Failure, FDA Warns

By on August 26, 2016

Onglyza (saxagliptin) was approved by the U.S. Food and Drug Administration (FDA) in 2009. The medication rapidly became a highly popular type 2 diabetes medication because it effectively controls blood sugar and does not cause weight gain like other medications of a similar type. But, it wasn’t long before these common side effects were linked to the drug, including the following: Read the rest »

Posted in: Pharmasuits

Can Daiichi Sankyo Inc. Be Held Liable for Benicar Side Effects?

By on August 24, 2016

Benicar, the brand name for olmesartan medoxomil, is manufactured by Japanese pharmaceutical giant Daiichi Sankyo. Over the years, Benicar has become a widely prescribed medication for hypertension and high blood pressure. Unfortunately, it has also been linked to the following side effects: Read the rest »

Posted in: Pharmasuits

Onglyza and Pancreatic Cancer

By on August 22, 2016

 

According to the American Diabetes Association, nearly 28 million Americans suffer from type 2 diabetes. This number is expected to grow as the population ages. The pharmaceutical industry sees this as a fertile marketplace for new type 2 diabetes medications. Among this new generation of drugs is Onglyza (saxagliptin), which was approved by the U.S. Food and Drug Administration (FDA) in 2009. Read the rest »

Posted in: Pharmasuits

NBA Star and Xarelto Pitchman Chris Bosh Misses Playoffs with Blood Clots

By on August 19, 2016

Miami Heat power forward Chris Bosh was forced to miss the NBA playoffs this year due to a blood clot in his calf (an injury known as deep vein thrombosis, or DVT). This is the second time that a blood clot has sidelined the 11 time All-Star’s career. He missed last year’s All-Star game because a blood clot had traveled to his lung (an injury known as a pulmonary embolism). Between the two blood clot episodes, Bosh added to his fame by becoming a spokesperson for the blood thinning medication Xarelto (Rivaroxaban). He even stars in a commercial with PGA great Arnold Palmer, comedian Kevin Nealon, and NASCAR driver Kevin Vickers. During the spot, all four men can be seen and heard praising the top selling anticoagulant.

Read the rest »

Posted in: Pharmasuits

California Man Blames Xarelto for Subdural Hematoma

By on August 17, 2016

A California man has filed a personal injury claim against both the manufacturer and marketer of Xarelto (rivaroxaban): Bayer AG and Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals. The man says he began taking the anticoagulant in July of 2013 to reduce the risk of stroke associated with atrial fibrillation. He had been prescribed the medication by his physician. The man continued taking the medication until April 2014, when he suffered life threatening bleeding and a subdural hematoma that caused severe and permanent physical injuries.

Read the rest »

Posted in: Pharmasuits


Need help now? Speak with a
Patient Advocate now:
855-797-9899

Who We Are

The pharmaceutical litigation attorneys at Farah & Farah go after negligent corporations that put unsuspecting consumers in harm's way. Pharmaceutical companies not only have a duty to manufacture drugs that are safe, but they also have the obligation to warn consumers regarding dangerous side effects that can be caused by these drugs.

Learn More